‘Persistent and severe misconduct’ triggers call for reform of UK drug marketing regulation

Fierce Pharma June 21, 2024
Nick Paul Taylor

“Persistent and severe misconduct” by pharma companies in the U.K. shows the inadequacy of existing self-regulation of marketing, according to researchers who analyzed complaints from 2004 to 2021.

The analysis, details of which were published in the journal Regulation & Governance, looked at almost 1,800 complaints against pharma companies in the U.K. The goal of the research was to understand the effectiveness of self-regulation by looking at changes in metrics over time and by comparing U.K. data to figures from elsewhere in Europe.

Analyzing the U.K. data revealed repeat offenders. Self-regulatory body the PMCPA ruled 159 companies had breached the rules over the analyzed period. Twenty of the companies received sanctions in at least half of the analyzed years....

Today's Sponsors

Today's Sponsor